How to watch Illumina's J.P. Morgan healthcare conference webcast

CellDeep-sea megafauna co-opts microbial energy metabolism genes to withstand ultra-long starvation

CellReplaying germinal center evolution on a quantified affinity landscape

CellXenophagocytosis blockade enhances interspecies chimerism

FierceBiotechADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buy

Endpoints News#ADA26: Pfizer monthly shot shows effect on obesity, diabetes

Endpoints News#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year

Endpoints NewsLawmakers propose China restrictions; #ASCO26 recap; and more

FierceBiotech‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs

AmgenAmgen: A Biotech Giant's Path to Recovery and Growth - AOL.com

AmgenAmgen: A Biotech Giant's Path to Recovery and Growth - The Motley Fool

Novo NordiskNovo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026 - PR Newswire